Literature DB >> 12141810

Octreotide for gastrointestinal bleeding of obscure origin in an anticoagulated patient.

Luke T Nordquist, Paul M Wallach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12141810     DOI： 10.1023/a:1015858917196

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  10 in total

Review 1.  Somatostatin and the gastrointestinal tract.

Authors:  Z Tulassay
Journal:  Scand J Gastroenterol Suppl       Date:  1998

2.  Somatostatin and ranitidine in the control of iatrogenic haemorrhage of the upper gastrointestinal tract.

Authors:  F Coraggio; P Scarpato; M Spina; S Lombardi
Journal:  Br Med J (Clin Res Ed)       Date:  1984-07-28

3.  Somatostatin and cimetidine in peptic-ulcer haemorrhage. A randomised controlled trial.

Authors:  L Kayasseh; K Gyr; U Keller; G A Stalder; M Wall
Journal:  Lancet       Date:  1980-04-19       Impact factor: 79.321

4.  The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract.

Authors:  G Nardone; A Rocco; T Balzano; G Budillon
Journal:  Aliment Pharmacol Ther       Date:  1999-11       Impact factor: 8.171

Review 5.  Pharmacologic therapy of arteriovenous malformations.

Authors:  E Van Cutsem; H Piessevaux
Journal:  Gastrointest Endosc Clin N Am       Date:  1996-10

Review 6.  Somatostatin for upper gastrointestinal hemorrhage and pancreatic surgery. A review of its pharmacology and safety.

Authors:  C Scarpignato; I Pelosini
Journal:  Digestion       Date:  1999       Impact factor: 3.216

Review 7.  Drug therapy for non-variceal upper gastrointestinal bleeding. Assessment of options.

Authors:  S A Jenkins
Journal:  Digestion       Date:  1999       Impact factor: 3.216

8.  Octreotide in the treatment of gastrointestinal bleeding caused by angiodysplasia in two patients with von Willebrand's disease.

Authors:  M Bowers; O McNulty; E Mayne
Journal:  Br J Haematol       Date:  2000-03       Impact factor: 6.998

9.  Octreotide for arrest of peptic ulcer hemorrhage--a prospective, randomized controlled trial.

Authors:  H J Lin; C L Perng; K Wang; C H Lee; S D Lee
Journal:  Hepatogastroenterology       Date:  1995 Nov-Dec

10.  The role of somatostatin and a long-acting analogue, SMS 201-995, in acute bleeding due to peptic ulceration.

Authors:  J Christiansen; A Yotis
Journal:  Scand J Gastroenterol Suppl       Date:  1986
  10 in total
  4 in total

1.  Use of octreotide in the management of severe duodenal bleeding after unrelated-donor bone marrow transplantation.

Authors:  Kazuteru Ohashi; Masaki Sanaka; Yuji Tanaka; Yoshiki Okuyama; Kiyoshi Hiruma; Hideki Akiyama; Hisashi Sakamaki
Journal:  Int J Hematol       Date:  2003-08       Impact factor: 2.490

Review 2.  Pharmacological therapy of vascular malformations of the gastrointestinal tract.

Authors:  Andrew Szilagyi; Maged P Ghali
Journal:  Can J Gastroenterol       Date:  2006-03       Impact factor: 3.522

3.  Radiofrequency ablation using Barrx® for the endoscopic treatment of gastric antral vascular ectasia: a series of three cases and a review of the literature on treatment options.

Authors:  Anish Patel; Sunil Patel; Prasanna C Wickremesinghe; Deepak Vadada
Journal:  Clin Exp Gastroenterol       Date:  2017-07-10

4.  Efficacy and safety of pasireotide-LAR for the treatment of refractory bleeding due to gastrointestinal angiodysplasias: results of the ANGIOPAS multicenter phase II noncomparative prospective double-blinded randomized study.

Authors:  Robert Benamouzig; Mourad Benallaoua; Jean-Christophe Saurin; Marouane Boubaya; Christophe Cellier; René Laugier; Magalie Vincent; Christian Boustière; Rodica Gincul; Elia Samaha; Philippe Grandval; Thomas Aparicio; Gheorghe Airinei; Bakhtiar Bejou; Cyriaque Bon; Jean-Jacques Raynaud; Vincent Levy; Denis Sautereau
Journal:  Therap Adv Gastroenterol       Date:  2018-02-16       Impact factor: 4.409
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.